Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. [electronic resource] by
- Bézay, Nicole
- Ayad, Andrea
- Dubischar, Katrin
- Firbas, Christa
- Hochreiter, Romana
- Kiermayr, Sigrid
- Kiss, István
- Pinl, Fritz
- Jilma, Bernd
- Westritschnig, Kerstin
Producer: 20171010
In:
Vaccine vol. 34
Availability: No items available.
|
|
17.
|
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. [electronic resource] by
- Reisinger, Emil C
- Tschismarov, Roland
- Beubler, Eckhard
- Wiedermann, Ursula
- Firbas, Christa
- Loebermann, Micha
- Pfeiffer, Andrea
- Muellner, Matthias
- Tauber, Erich
- Ramsauer, Katrin
Producer: 20190225
In:
Lancet (London, England) vol. 392
Availability: No items available.
|
|
18.
|
Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers. [electronic resource] by
- Schoergenhofer, Christian
- Buchtele, Nina
- Gelbenegger, Georg
- Derhaschnig, Ulla
- Firbas, Christa
- Kovacevic, Katarina D
- Schwameis, Michael
- Wohlfarth, Philipp
- Rabitsch, Werner
- Jilma, Bernd
Producer: 20201028
In:
Scientific reports vol. 9
Availability: No items available.
|
|
19.
|
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. [electronic resource] by
- Ramsauer, Katrin
- Schwameis, Michael
- Firbas, Christa
- Müllner, Matthias
- Putnak, Robert J
- Thomas, Stephen J
- Desprès, Philippe
- Tauber, Erich
- Jilma, Bernd
- Tangy, Frederic
Producer: 20150714
In:
The Lancet. Infectious diseases vol. 15
Availability: No items available.
|
|
20.
|
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. [electronic resource] by
- Schwameis, Michael
- Roppenser, Bernhard
- Firbas, Christa
- Gruener, Corina S
- Model, Nina
- Stich, Norbert
- Roetzer, Andreas
- Buchtele, Nina
- Jilma, Bernd
- Eibl, Martha M
Producer: 20170612
In:
The Lancet. Infectious diseases vol. 16
Availability: No items available.
|